These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15472292)

  • 1. Serotypes and sequence types of pneumococci causing invasive disease in Scotland prior to the introduction of pneumococcal conjugate polysaccharide vaccines.
    Clarke SC; Scott KJ; McChlery SM
    J Clin Microbiol; 2004 Oct; 42(10):4449-52. PubMed ID: 15472292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland.
    Clarke SC; Jefferies JMC; Smith AJ; McMenamin J; Mitchell TJ; Edwards GFS
    J Med Microbiol; 2006 Aug; 55(Pt 8):1079-1084. PubMed ID: 16849728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
    Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
    Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3-year cross-sectional population based analysis.
    Tocheva AS; Jefferies JM; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2013 Jun; 31(31):3187-90. PubMed ID: 23680442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
    Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
    Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.
    Sá-Leão R; Pinto F; Aguiar S; Nunes S; Carriço JA; Frazão N; Gonçalves-Sousa N; Melo-Cristino J; de Lencastre H; Ramirez M
    J Clin Microbiol; 2011 Apr; 49(4):1369-75. PubMed ID: 21270219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotypes and genotypes of Streptococcus pneumoniae isolates from Trinidad and Tobago.
    Nurse-Lucas M; McGee L; Hawkins PA; Swanston WH; Akpaka PE
    Int J Infect Dis; 2016 May; 46():100-6. PubMed ID: 27062986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy.
    McChlery SM; Scott KJ; Clarke SC
    Eur J Clin Microbiol Infect Dis; 2005 Apr; 24(4):262-7. PubMed ID: 15902532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.
    Weil-Olivier C; van der Linden M; de Schutter I; Dagan R; Mantovani L
    BMC Infect Dis; 2012 Sep; 12():207. PubMed ID: 22954038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011.
    Horácio AN; Silva-Costa C; Diamantino-Miranda J; Lopes JP; Ramirez M; Melo-Cristino J;
    PLoS One; 2016; 11(5):e0153602. PubMed ID: 27168156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.
    Clarke SC; Jefferies JM; Smith AJ; McMenamin J; Mitchell TJ; Edwards GF
    J Clin Microbiol; 2006 Apr; 44(4):1224-8. PubMed ID: 16597842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Diekema DJ; Doern GV
    Emerg Infect Dis; 2013 Jul; 19(7):1074-83. PubMed ID: 23763847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
    J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.